STJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. St Jude Medical Inc's research and development for the three months ended in Dec. 2014 was $175 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2014 was $692 Mil.
This is the expense the company spent on research and development.
St Jude Medical Inc Research & Development for the trailing twelve months (TTM) ended in Dec. 2014 was 170 (Mar. 2014 ) + 178 (Jun. 2014 ) + 169 (Sep. 2014 ) + 175 (Dec. 2014 ) = $692 Mil.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
St Jude Medical Inc Annual Data
|Research & Development||369||431||476||532||560||643||709||676||691||692|
St Jude Medical Inc Quarterly Data
|Research & Development||170||158||160||173||172||186||170||178||169||175|